ScoreWhy is PhoenixBio Co., Ltd. ?
1
Poor Management Efficiency with a low ROE of 6.82%
- The company has been able to generate a Return on Equity (avg) of 6.82% signifying low profitability per unit of shareholders funds
2
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 6.82%
3
With a growth in Operating Profit of 1802.03%, the company declared Outstanding results in Dec 25
- The company has declared positive results in Jan 70 after 8 consecutive negative quarters
- RAW MATERIAL COST(Y) Fallen by -15.86% (YoY)
- DEBTORS TURNOVER RATIO(HY) Highest at 8.07 times
- NET SALES(Q) Highest at JPY 444.36 MM
4
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 22.52%, its profits have fallen by -1823.5%
5
Underperformed the market in the last 1 year
- The stock has generated a return of 22.52% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 38.30%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to PhoenixBio Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is PhoenixBio Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
PhoenixBio Co., Ltd.
22.52%
-0.09
76.96%
Japan Nikkei 225
40.96%
1.35
28.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.29%
EBIT Growth (5y)
-48.37%
EBIT to Interest (avg)
-52.54
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.53
Sales to Capital Employed (avg)
0.79
Tax Ratio
3.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.86%
ROE (avg)
6.82%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.16
EV to EBIT
-2.99
EV to EBITDA
-3.31
EV to Capital Employed
1.33
EV to Sales
0.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-44.46%
ROE (Latest)
-34.39%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend24What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -15.86% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 8.07 times
NET SALES(Q)
Highest at JPY 444.36 MM
OPERATING PROFIT(Q)
Highest at JPY 72.1 MM
OPERATING PROFIT MARGIN(Q)
Highest at 16.22 %
PRE-TAX PROFIT(Q)
Highest at JPY 82.3 MM
NET PROFIT(Q)
Highest at JPY 80.91 MM
EPS(Q)
Highest at JPY 19.88
-3What is not working for the Company
CASH AND EQV(HY)
Lowest at JPY 1,966.68 MM
DEBT-EQUITY RATIO
(HY)
Highest at -38.37 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.84 times
Here's what is working for PhoenixBio Co., Ltd.
Pre-Tax Profit
At JPY 82.3 MM has Grown at 1,997.86%
over average net sales of the previous four periods of JPY -4.34 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (JPY MM)
Net Profit
At JPY 80.91 MM has Grown at 989.13%
over average net sales of the previous four periods of JPY -9.1 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (JPY MM)
Net Sales
Highest at JPY 444.36 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Net Sales
At JPY 444.36 MM has Grown at 17.75%
over average net sales of the previous four periods of JPY 377.38 MMMOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Operating Profit
Highest at JPY 72.1 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (JPY MM)
Operating Profit Margin
Highest at 16.22 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at JPY 82.3 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Net Profit
Highest at JPY 80.91 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
EPS
Highest at JPY 19.88
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (JPY)
Debtors Turnover Ratio
Highest at 8.07 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -15.86% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at JPY 9.19 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)
Here's what is not working for PhoenixBio Co., Ltd.
Cash and Eqv
Lowest at JPY 1,966.68 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -38.37 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 0.84 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
